Bardoxolone methyl - IκB/IKK - NF-κB - Reference Compounds Your lab for organic synthesis
APExBIO - Bardoxolone methyl|IKK inhibitor, potent antioxidant inflammation modulator|CAS# 218600-53-4
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
SID 135650061 - PubChem
NF-kB Signaling Pathway products from Selleck Chemicals
Cancers | Free Full-Text | Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer
Signaling pathways of chronic kidney diseases, implications for therapeutics | Signal Transduction and Targeted Therapy
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease - ScienceDirect
Synthesis, Biological Evaluation, and Molecular Docking Study of 3-Amino and 3-Hydroxy-seco A Derivatives of α-Amyrin and 3-Epilupeol as Inhibitors of COX-2 Activity and NF-kB Activation | Journal of Natural Products
JCM | Free Full-Text | Inflammatory Targets in Diabetic Nephropathy
Changes from baseline in body weight with bardoxolone methyl by... | Download Scientific Diagram
Pharmacodynamics of bardoxolone methyl. A, levels of NF- k B, cyclin... | Download Scientific Diagram
Bardoxolone methyl (RTA 402) | ≥99%(HPLC) | IκB/IKK inhibitor | AdooQ®
Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure | Journal of Pharmacology and Experimental Therapeutics
Divulging the Intricacies of Crosstalk Between NF-Kb and Nrf2-Keap1 Pathway in Neurological Complications of COVID-19 | SpringerLink
CDDO-Me | Cell Signaling Technology
Figure 2 from Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties | Semantic Scholar
Bardoxolone conjugation enables targeted protein degradation of BRD4 | Scientific Reports
Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells | Molecular Pharmacology
Design and Synthesis of Irreversible Analogues of Bardoxolone Methyl for the Identification of Pharmacologically Relevant Targets and Interaction Sites | Journal of Medicinal Chemistry
Bardoxolone methyl | 218600-53-4
Molecules | Free Full-Text | Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease
reta-10k_20171231.htm
Antioxidants | Free Full-Text | Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls
Bardoxolone methyl - Wikipedia
Role of NF-κB, PI3K and AKT pathways in ASC-mediated... | Download Scientific Diagram
